Colorado Blood Cancer Institute at Presbyterian/St. Luke's Medical Center/Sarah Cannon Research Institute is a clinical research site located in Denver, Colorado, United States 80218.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
Colorado Blood Cancer Institute at Presbyterian/St. Luke's Medical Center/Sarah Cannon Research Institute has participated in 1 clinical trials.
Therapeutic areas: Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL).
Sponsors: Autolus Limited.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Colorado Blood Cancer Institute at Presbyterian/St. Luke's Medical Center/Sarah Cannon Research Institute has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Colorado Blood Cancer Institute at Presbyterian/St. Luke's Medical Center/Sarah Cannon Research Institute has 1 clinical trials on record. Their work covers Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL).
Colorado Blood Cancer Institute at Presbyterian/St. Luke's Medical Center/Sarah Cannon Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.